Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 31, 2018 07:30 ET | Source: VIVUS, Inc.

VIVUS to Host Second Quarter Business Update and Financial Results Conference Call on Tuesday, August 7, 2018

CAMPBELL, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it will report financial results and provide a business update for the second quarter of...
July 10, 2018 07:30 ET | Source: VIVUS, Inc.

VIVUS Announces Positive Results from a Phase 1 Clinical Trial of VI-0106

-Favorable pharmacokinetic results add to body of data supporting continued development in the treatment of pulmonary arterial hypertension- CAMPBELL, Calif., July 10, 2018 (GLOBE NEWSWIRE) --...
June 11, 2018 07:30 ET | Source: VIVUS, Inc.

VIVUS Executes on its Strategic Vision with the Closing of its Acquisition of PANCREAZE® and Previously Announced Financing Transaction

CAMPBELL, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the “Company”), a biopharmaceutical company, today announced that it has met the closing conditions, including...
May 08, 2018 16:05 ET | Source: VIVUS, Inc.

VIVUS Reports First Quarter 2018 Financial Results

Company provides business update on PANCREAZE® acquisition, new Athyrium debt line and new management Company to host conference call today at 4:30pm ET CAMPBELL, Calif., May 08, 2018 (GLOBE...
May 04, 2018 16:05 ET | Source: VIVUS, Inc.

VIVUS Announces Date of 2018 Annual Meeting

CAMPBELL, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the “Company”), a biopharmaceutical company, today announced that the Company will hold its 2018 Annual Meeting of...
May 01, 2018 07:05 ET | Source: VIVUS, Inc.

VIVUS Expands its Commercial Product Portfolio with the Acquisition of PANCREAZE®

CAMPBELL, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the “Company”), a biopharmaceutical company, today announced that it has entered into a definitive agreement to acquire...
May 01, 2018 07:00 ET | Source: VIVUS, Inc.

VIVUS Restructures Debt and Gains Access to New Capital

Athyrium Capital Management partners with VIVUS to support next growth phase New capital to be used to facilitate the acquisition of PANCREAZE® (pancrelipase) CAMPBELL, Calif. and NEW YORK, May 01,...
October 28, 2015 07:00 ET | Source: VIVUS, Inc.

VIVUS Announces Date of Third Quarter 2015 Update and Financial Results Teleconference

MOUNTAIN VIEW, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ:VVUS) today announced that it will provide an update and report financial results for the third quarter ended September 30,...
July 23, 2015 07:00 ET | Source: VIVUS, Inc.

VIVUS Announces Date of Second Quarter 2015 Update and Financial Results Conference Call

MOUNTAIN VIEW, Calif., July 23, 2015 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ:VVUS) today announced that it will provide an update and report financial results for the second quarter ended June 30,...
April 30, 2015 07:00 ET | Source: VIVUS, Inc.

VIVUS Announces Date of First Quarter 2015 Update and Financial Results Conference Call

MOUNTAIN VIEW, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will provide an update and report financial results for the first quarter ended March 31,...